Page 1174 - Clinical Small Animal Internal Medicine
P. 1174

1112  Section 10  Renal and Genitourinary Disease

            administer crystalloid “shock doses” (80–90 mL/kg dog,   centesis. Cystocentesis can allow an uncontaminated
  VetBooks.ir  40–60 mL/kg  cat)  in bolus  fractions  (1/4  to  1/3 shock   urine sample to be obtained for urinalysis and/or urine
                                                              culture. Finally, it is speculated that decreasing intralu­
            dose over 15–30 minutes, repeated as necessary) to rap­
            idly restore vascular volume. If resuscitation is not nec­
                                                              catheter. The major counterargument against the use of
            essary, fluid rate should be based on replacement of   minal pressure may make for easier passage of a urinary
            dehydration added to the maintenance fluid require­  cystocentesis is related to the concern for bladder tear or
            ment. If time does not allow more accurate determina­  rupture. While this is a known potential side‐effect
            tion of fluid rate, it is reasonable to start at a rate of   whenever  cystocentesis  is  performed,  it  is  believed  by
            10 mL/kg  in  the  initial  stages  and  then  reassess.  Care   some that a distended and friable bladder present with
            must also be taken with the amount of fluids given, espe­  UO is associated with increased risk. There is evidence
            cially in cats, as a recent study has shown that cats with   to suggest that development of clinically significant
            UO are at risk for volume overload.               abdominal effusion, as shown by abdominal ultrasound
             While urinary catheter placement and IV fluids will be   or radiographs, occurs very uncommonly after cystocen­
            important in addressing the underlying cause, there is a   tesis in cats with UO and that this procedure can be
            significant delay for glomerular filtration rate (GFR) to   safely performed. Similar information regarding cysto­
            resume and for potassium excretion to occur. Calcium   centesis in dogs with UO is currently unavailable.
            gluconate is the most immediate way to offset the effects
            of hyperkalemia on electric conduction, though this   Urethral catheterization
            medication does not decrease the potassium itself. In   Urinary catheter placement is an important step in the
            addition, medications that promote intracellular shift of   management of UO. In this process, every effort should
            potassium include regular insulin, dextrose, terbutaline,   be made to minimize the risk of urethral trauma and
            and/or sodium bicarbonate (see Table 122.1 for dosing   optimize the likelihood of successful catheterization.
            recommendations).                                 Along these lines, UO patients should receive appropri­
             Generally, if it was deemed necessary to give calcium   ate sedation and pain medication, with consideration of
            gluconate, then one or more of these medications should   coccygeal epidural  and/or  general anesthesia. In addi­
            also be given. It should be noted that dextrose should   tion to impacts on patient comfort and standard of care,
            always be given with insulin to prevent the development   inadequate analgesia and  sedation  may be associated
            of hypoglycemia.                                  with urethral spasm and urethral injury. If the patient is
             There is also consideration of cystocentesis as part of   still reactive to effort (vocalizing, moving), additional
            initial management. On the one hand, it may allow for   medications should be given; alternatively, general anes­
            more immediate relief of bladder pressure compared to   thesia should be performed.
            urinary catheter placement (particularly for those with   For cats, the perineal region should be clipped, prepped,
            limited experience in deobstructing). In addition, rela­  and draped in order to minimize risk of contamination.
            tively less sedation is typically needed to perform cysto­  An open‐ended semi‐rigid catheter (polypropylene or



            Table 122.1  Emergency dosing for severe hyperkalemia. All medications given intravenously (IV)

             Medication          Dose (IV)          Rate                              Indications
             Isotonic crystalloid  10–15 mL/kg (c)  15–30 minutes, repeat if needed   Shock
                                 20–30 mL/kg (d)    Constant rate infusion            Replacement fluid rate
                                 5–10 mL/kg/h
             Calcium gluconate   50–150 mg/kg       Over 5 minutes while monitoring ECG  Severe ECG changes
                                                                                      Bradycardia
             Regular insulin     1 unit (c)         IV bolus                          If Ca gluconate given
                                 0.1 U/kg (d)                                         Potassium >8 mEq/L
             Dextrose            0.5 g/kg           Admin over 3–5 min                If Ca gluconate given
                                                                                      If insulin given
                                 2.5–5% in fluids   Constant rate infusion            Potassium >8 mEq/L
             Terbutaline         0.01 mg/kg         IV bolus                          If Ca gluconate given
                                                                                      Potassium >8 mEq/L
             Sodium bicarb       1 mEq/kg           Admin over 3–5 min                Potassium >10 mEq/L
            c, cat; d, dog; ECG, electrocardiogram.
   1169   1170   1171   1172   1173   1174   1175   1176   1177   1178   1179